Impact on disease development, genomic location and biological function of copy number alterations in non-small cell lung cancer

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Huang, Yen Tsung ^a   Lin, Xihong ^a   Chirieac, Lucian R ^b   McGovern, Ray ^a   Wain, John C ^c   Heist, Rebecca S ^a,c   Skaug, Vidar ^d   Zienolddiny, Shanbeh ^d   Haugen, Aage ^d   Su, Li ^a   Christiani, David C ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; COPY NUMBER VARIATION; DISEASE COURSE; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; GENE DOSAGE; GENETICS; LUNG TUMOR;

CARCINOMA, NON-SMALL-CELL LUNG; GENE DOSAGE; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; ONCOGENES;

EID: 79960974076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022961     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
3. Kim TM, Yim SH, Lee JS, Kwon MS, Ryu JW, et al. (2005) Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res 11: 8235-8242.
4. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
5. Duesberg P, Li R, Fabarius A, Hehlmann R, (2005) The chromosomal basis of cancer. Cell Oncol 27: 293-318.
6. Duesberg P, (2005) Does aneuploidy or mutation start cancer? Science 307: 41.
7. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
8. Zhao X, Li C, Paez JG, Chin K, Janne PA, et al. (2004) An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64: 3060-3071.
9. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Statist Soc Ser B 57: 289-300.
10. Storey J, (2002) A direct approach to false discovery rates. Journal of the Royal Statistical Society, Series B 64: 479-498.
11. Emerson JJ, Cardoso-Moreira M, Borevitz JO, Long M, (2008) Natural selection shapes genome-wide patterns of copy-number polymorphism in Drosophila melanogaster. Science 320: 1629-1631.
12. Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, et al. (2007) Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 56: 175-184.
13. Okudela K, Suzuki M, Kageyama S, Bunai T, Nagura K, et al. (2007) PIK3CA mutation and amplification in human lung cancer. Pathol Int 57: 664-671.
14. Kang JU, Koo SH, Kwon KC, Park JW, Jung SS, (2008) Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung. Cancer Genet Cytogenet 184: 31-37.
15. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM, (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182: 1-11.
16. Yamamoto H, Shigematsu H, Nomura M, Lockwood WW, Sato M, et al. (2008) PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 68: 6913-6921.
17. Hastings PJ, Lupski JR, Rosenberg SM, Ira G, (2009) Mechanisms of change in gene copy number. Nat Rev Genet 10: 551-564.
18. Shlien A, Malkin D, (2009) Copy number variations and cancer. Genome Med 1: 62.
19. Mitsuuchi Y, Testa JR, (2002) Cytogenetics and molecular genetics of lung cancer. Am J Med Genet 115: 183-188.
20. Osada H, Takahashi T, (2002) Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21: 7421-7434.
21. Sanchez-Cespedes M, (2003) Dissecting the genetic alterations involved in lung carcinogenesis. Lung Cancer 40: 111-121.
22. Panani AD, Roussos C, (2006) Cytogenetic and molecular aspects of lung cancer. Cancer Lett 239: 1-9.
23. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
24. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, et al. (2003) Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 63: 859-864.
25. Cohen HT, McGovern FJ, (2005) Renal-cell carcinoma. N Engl J Med 353: 2477-2490.
26. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-484.
27. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
28. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, et al. (2004) High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A 101: 9067-9072.